allcancercure.com

Bristol scientists have found that red blood cell transfusions given to people having heart surgery could increase the risk of heart attack or stroke. Published in the latest issue [November 27] of the journal Circulation, the study looked at the association between red blood cell transfusion and adverse outcomes in over 8,500 cardiac surgery patients [...]

The European Medicines Agency (EMEA) has recommended the suspension of the marketing authorisations of all medicinal products for systemic use containing aprotinin. Aprotinin is used to reduce blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery. Following a review during its November [...]

Researchers from the Abramson Cancer Center of the University of Pennsylvania announced that findings from two large, international clinical trials show unprecedented survival for patients with multiple myeloma, a cancer that occurs in the blood-making cells of bone marrow. The findings show that when the oral drug lenalidomide (REVLIMID®), is taken in combination with the [...]

A collaboration between researchers in Switzerland, the UK and France has led to the solution of the first crystal structure of a member of the Rhesus protein family and thereby shed new light on a group of proteins of great importance in human transfusion medicine. The UK group was led by Professor Mike Merrick in [...]

An All-Party Parliamentary Report published exposes NHS Trusts in unnecessary DVT deaths. Over 10,700 hospital patients may have died as a result of NHS Trusts’ failure to implement key recommendations on DVT published over seven months ago.1, 2 – Unnecessary deaths from DVT in the last seven months may equate to nearly three times the [...]

Findings from three phase III clinical trials of rivaroxaban will be presented in the plenary session and during oral presentations at the American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia, from December 8 to 11, 2007. Rivaroxaban is being jointly developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and Bayer HealthCare, [...]

This summer, 36 medical students, undergraduates, and residents each received $4,000 to conduct research on blood and blood-related diseases. These Trainee Research Awards, provided by the American Society of Hematology (ASH), are designed to encourage the pursuit of research and spark an interest in the specialty. Travel stipends are also provided to these investigators to [...]